Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats

Infection and Immunity

Volumn 65, Issue 8, 1997, Pages 3438-3443

  Littlewood Evans, A J ^a   Hattenberger, M R ^a   Luscher C ^a   Pataki, A ^a   Zak, O ^a   O'Reilly, T ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NONHUMAN; OSTEOLYSIS; OSTEOMYELITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAPHYLOCOCCUS AUREUS;

EID: 0030798903     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.8.3438-3443.1997     Document Type: Article

References (40)

1. Aliabadi, P., and N. Nikpoor. 1994. Imaging osteomyelitis. Arthritis Rheum. 37:617-622.
2. Bertolini, D. R., G. E. Nedwin, T. S. Bringman, D. D. Smith, and G. R. Mundy. 1986. Stimulation of hone resorption and inhibition of bone formation in vitro by human tumour necrosis factor. Nature 319:516-518.
3. Beutler, B., and A. Cerami. 1987. Cachectin: more than a tumor necrosis factor. New Engl. J. Med. 316:379-385.
4. Boyce, B. F., T. B. Aufdemorte, I. R. Garrett, A. J. P. Yates, and G. R. Mundy. 1989. Effects of interleukin 1 on bone turnover in normal mice. Endocrinology 125:1142-1150.
5. Buchan, G., K. Barrett, M. Turner, D. Chantry, R. N. Maini, and M. Feldmann. 1988. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin. Exp. Immunol. 73:449-455.
6. Centrella, M., T. L. McCarthy, and E. Canalis. 1988. Tumour necrosis factor-α inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. Endocrinology 123:1442-1448.
7. Chikanza, I. C., P. Roux-Lombard, J. M. Dayer, and G. S. Panayi. 1993. Tumour necrosis soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis. Clin. Exp. Immunol. 92:19-22.
8. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
9. Chu, C. Q., M. Field, M. Feldmann, and R. N. Maini. 1991. Localization of tumour necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34:1125-1132.
10. Cunningham, R., A. Cockayne, and H. Humphreys. 1996. Clinical and molecular aspects of Staphylococcus aureus bone and joint infections. J. Med. Microbiol. 44:157-164.
11. Denk, H., H. Künzle, H. Plenkje, J. Rüschoff, and W. Sellner. 1989. Trichromfärbung nach Goldner, p. 558. In P. Bröck (ed.), Romeis Mikros-kopische Technik, 17th ed. Urban und Schwarzenberg, Munich, Germany.
12. Descoteaux, A., and G. Matlashewski. 1990. Regulation of tumour necrosis factor gene expression and protein synthesis in murine macrophages treated with recombinant tumour necrosis factor. J. Immunol. 145:846-853.
13. Dickie, A. S. 1986. Current concepts in the management of infections in bones and joints. Drugs 32:458-475.
14. Dodds, R. A., K. Merry, A. Littlewood, and M. Gowen. 1994. Expression of mRNA for IL-1β, IL-6 and TGFβ1 in developing human bone and cartilage. J. Histochem. Cytochem. 42:733-744.
15. Elliott, M. J., R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, P. Matsikis, F. M. Brennan, J. Walker, H. Bijl, J. Ghrayeb, and J. N. Woody. 1993. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumour necrosis factor α Arthritis Rheum. 36:1681-1690.
16. Garrett, I. R., B. G. M. Durie, G. E. Nedwin, A. Gillespie, T. Bringman, M. Sabatini, D. R. Bertolini, and G. R. Mundy. 1987. Production of the bone resorbing cytokine lymphotoxin by cultured human myeloma cells. New Engl. J. Med. 317:526-532.
17. Gillaspy, A. F., S. G. Hickmon, R. A. Skinner, J. R. Thomas, C. L. Nelson, and M. S. Smeltzer. 1995. Role of the accessory gene regulator (agr) in pathogencsis of staphylococcal osteomyelitis. Infect. Immun. 63:3373-3380.
18. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNFα/cachectin. Nature 346:274-276.
19. Gowen, M., K. Chapman, A. Littlewood, D. Hughes, D. Evans, and G. Russell. 1990. Production of tumour necrosis factor by human osteoblasts is modulated by other cytokines. but not by osteotropic hormones. Endocrinology 126:1250-1255.
20. Gowen, M., B. R. MacDonald, and R. G. Russell. 1988. Actions of recombinant human gamma-interferon and tumour necrosis factor alpha on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis Rheum. 31:1500-1507.
21. Keffer, J., L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, and G. Killias. 1991. Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J. 10:4025-4031.
22. Klosterhalfen, B., K. M. Peters, C. Töns, S. Hauptmann, C. L. Klein, and C. J. Kirkpatrick. 1996. Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis. J. Trauma 40: 372-378.
23. 3H]-tetracycline excretion from prelabelled mice. J. Bone Miner. Res. 3:621-627.
24. Littlewood, A. J., L. A. Aarden, D. B. Evans, R. G. G. Russell, and M. Gowen. 1991. Human osteoblast-like cells do not respond to interleukin 6. J. Bone Miner, Res. 6:141-148.
25. Mundy, G. R. 1993. Cytokines and growth factors in the regulation of bone remodelling. J. Bone Miner. Res. 8(Suppl. 2):S505-S510.
26. Nair, S., Y. Song, S. Meghji, K. Reddi, M. Harris, A. Ross, S. Poole, M. Wilson, and B. Henderson. 1995. Surface associated proteins from Staphylococcus aureus demonstrate potent bone resorbing activity. J. Bone Miner. Res. 10:726-734.
27. Nair, S. P., S. Meghji, M. Wilson, K. Reddi, P. White, and B. Henderson. 1996. Bacterialfy induced bone destruction: mechanisms and misconceptions. Infect. Immun. 64:2371-2380.
28. Norden, C. W. 1990. Osteomyelitis, p. 922-930. In G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett (ed.), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, New York, N.Y.
29. O'Reilly, T., S. Kunz, E. Sande, O. Zak, M. A. Sande, and M. G. Täuber. 1992. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. Antimicrob. Agents Chemother. 36:2693-2697.
30. Pacifici, R., L. Rifas, S. Teitelbaum, E. Slatopolsky, R. McCracken, M. Bergfeld, W. Lee, L. V. Avioli, and W. A. Peck. 1987. Spontaneous release of interleukin-1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc. Natl. Acad. Sci. USA 84:4616-4620.
31. Rooney, P., G. Bilbe, O. Zak, and T. O'Reilly. 1995. Dexamethasone treat- ment of lipopolysaccharide-induced meningitis in rabbits that mimics magnification of inflammation following antibiotic therapy. J. Med. Microbiol. 43:37-44.
32. Saklatavala, J. 1986. TNFα stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547-549.
33. Schmid, F. R. 1993. Principles of diagnosis and treatment of bone and joint infections, p. 1975-2001. In D. J. McCarty and W. J. Koopman (ed.), Arthritis and allied conditions, vol. 2. Lea and Febiger, Philadelphia, Pa.
34. Sosroseno, W., and E. Herminajeng. 1995. The immunopathology of chronic inflammatory periodontal disease. FEMS Immunol. Med. Microbiol. 10:171-180.
35. Sprenger, H., M. Bacher, E. Rischkowsky, A. Bender, M. Nain, and D. Gemsa. 1994. Characterization of a high molecular weight tumour necrosis factor-α mRNA in influenza A virus-infected macrophages. J. Immunol. 152:280-289.
36. Thomson, B. M., G. R. Mundy, and T. J. Chambers. 1987. Tumour necrosis factor α and β induce osteoblastic cells to stimulate osteoclast bone resorption. J. Immunol. 138:775-779.
37. Tracey, K. J., and A. Cerami. 1994. Tumour necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:491-503.
38. Waldvogel, F. A. 1990. Staphylococcus aureus (including toxic shock syndrome), p. 1489-1510. In G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett (ed.), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, New York, N.Y.
39. Wright, S. C., A. Jewett, R. Mitsuyasu, and B. Bonavida. 1988. Spontaneous cytotoxicity and tumour necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141:99-104.
40. Zak, O., F. Zak, R. Rich, W. Tosch, F. Kradolfer, and W. M. Scheid. 1981. Experimental staphylococcal osteomyelitis in rats: therapy with rifampicin and cloxacillin, alone or in combination, p. 973-974. In P. Periti and G. G. Grassi (ed.), Current chemotherapy and immunotherapy. Proceedings of the 12th International Congress of Chemotherapy. American Society for Microbiology, Washington, D.C.